Document
IPR2023-00724, No. 2009 Exhibit - EX2009 Declaration of Sayem Osman (P.T.A.B. Jul. 6, 2023)
Cite Document
IPR2023-00724, No. 2009 Exhibit - EX2009 Declaration of Sayem Osman (P.T.A.B. Jul. 6, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1030 Exhibit - Kim 2007 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1030 Exhibit - Kim 2007 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1079 Exhibit - NCT115 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1079 Exhibit - NCT115 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1046 Exhibit - Yun 2006 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1046 Exhibit - Yun 2006 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1062 Exhibit - Zarin 2011 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1062 Exhibit - Zarin 2011 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1036 Exhibit - Mojsov 1987 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1036 Exhibit - Mojsov 1987 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1072 Exhibit - US5164366 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1072 Exhibit - US5164366 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 2004 Exhibit - EX2004 Miller, M, et al, “Low Viscosity Highly Concentrated Injectable Nonaqueous Suspensions of Lysozyme Microparticles,” Langmuir, Author Manuscript 2...
Cite Document
IPR2023-00724, No. 2004 Exhibit - EX2004 Miller, M, et al, “Low Viscosity Highly Concentrated Injectable Nonaqueous Suspensions of Lysozyme Microparticles,” Langmuir, Author Manuscript 2011, PMC 201
+ More Snippets
Document
IPR2023-00724, No. 1085 Exhibit - J Med Chem (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1085 Exhibit - J Med Chem (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 2506 Exhibit - EX2506 Novo Nordisk, Financial report for the period 1 January 2021 to 31 March 2021 May 5, 2021 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2506 Exhibit - EX2506 Novo Nordisk, Financial report for the period 1 January 2021 to 31 March 2021 May 5, 2021 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2387 Exhibit - EX2387 American Heart Association, “Cardiovascular Disease and Diabetes,” httpswwwheartorgenhealth topicsdiabetesdiabetes complications and riskscar...
Cite Document
IPR2023-00724, No. 2387 Exhibit - EX2387 American Heart Association, “Cardiovascular Disease and Diabetes,” httpswwwheartorgenhealth topicsdiabetesdiabetes complications and riskscardiovascular dise
+ More Snippets
Document
IPR2023-00724, No. 2012 Exhibit - EX2012 Rossing, P, et al, “The rationale, design and baseline data of FLOW, a kidney outcomes trial with once weekly semaglutide in people with type 2 diabe...
Cite Document
IPR2023-00724, No. 2012 Exhibit - EX2012 Rossing, P, et al, “The rationale, design and baseline data of FLOW, a kidney outcomes trial with once weekly semaglutide in people with type 2 diabetes and
+ More Snippets
Document
IPR2023-00724, No. 2089 Exhibit - EX2089 American Society for Preventive Cardiology, “Cardiometabolic Fellowship,” httpswwwaspconlineorgprofessional developmentcardiometabolic fellows...
Cite Document
IPR2023-00724, No. 2089 Exhibit - EX2089 American Society for Preventive Cardiology, “Cardiometabolic Fellowship,” httpswwwaspconlineorgprofessional developmentcardiometabolic fellowship last visite
+ More Snippets
Document
IPR2023-00724, No. 2083 Exhibit - EX2083 V Aroda et al, “Efficacy and safety of once weekly semaglutide versus once daily insulin glargine as add on to metformin with or without sulfonylureas...
Cite Document
IPR2023-00724, No. 2083 Exhibit - EX2083 V Aroda et al, “Efficacy and safety of once weekly semaglutide versus once daily insulin glargine as add on to metformin with or without sulfonylureas in ins
+ More Snippets
Document
IPR2023-00724, No. 2457 Exhibit - EX2457 Soliqua 10033 Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2457 Exhibit - EX2457 Soliqua 10033 Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)
+ More Snippets